ILCO:TASEIsrael Corporation Ltd. Analysis
Data as of 2026-06-12 - not real-time
ILA 85,900.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Israel Corporation Ltd (ILCO) trades at 85,900, comfortably below its 20‑day (≈90,986) and 50‑day (≈89,275) moving averages, signaling short‑term technical weakness. The RSI of 40 hints at a modestly oversold condition, yet the bearish MACD and negative histogram underscore lingering momentum pressure. Despite a 30‑day volatility of 45.6%, the stock’s beta is exceptionally low (~0.06), suggesting that price swings are largely idiosyncratic rather than market‑driven. Fundamentally, the company posts a solid 14.5% revenue growth and a respectable PE of 19.4, but profit margins are thin (≈1.6%) and free cash flow is slightly negative. The balance sheet shows moderate leverage (debt‑to‑equity ~56%) with ample cash reserves, and a low dividend payout (13.5% of earnings) supports a dividend sustainability outlook. A discounted cash flow model values ILCO at roughly 192,500, more than double the current price, indicating a significant valuation gap amid an “Extreme Greed” market sentiment.
Given the supportive fundamentals, diversified geographic footprint, and attractive upside potential, the stock appears fundamentally undervalued. However, the technical side remains fragile, and high short‑term volatility calls for cautious positioning. Investors with a medium‑ to long‑term horizon may find the combination of growth prospects, modest dividend, and low systematic risk compelling, while short‑term traders should monitor support levels and momentum indicators before committing.
Given the supportive fundamentals, diversified geographic footprint, and attractive upside potential, the stock appears fundamentally undervalued. However, the technical side remains fragile, and high short‑term volatility calls for cautious positioning. Investors with a medium‑ to long‑term horizon may find the combination of growth prospects, modest dividend, and low systematic risk compelling, while short‑term traders should monitor support levels and momentum indicators before committing.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support
- Bearish MACD momentum
- Valuation upside vs DCF
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth exceeding 14%
- Significant valuation gap to DCF fair value
- Low payout ratio supporting dividend sustainability
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Diversified global operations reducing single‑country exposure
- Low beta indicating limited market‑wide risk
- Undervalued fundamentals with potential for earnings expansion
Key Metrics & Analysis
Financial Health
Revenue Growth14.50%
Profit Margin1.55%
P/E Ratio19.4
ROE4.67%
ROA3.26%
Debt/Equity56.09
P/B Ratio2.1
Op. Cash FlowILA1.0B
Free Cash FlowILA-15000000
Technical Analysis
TrendNeutral
RSI40.0
SupportILA 83,010.00
ResistanceILA 98,600.00
MA 20ILA 90,986.00
MA 50ILA 89,274.80
MA 200ILA 94,777.20
MACDBearish
VolumeIncreasing
Fear & Greed Index88.27
Valuation
Fair ValueILA 192,524.03
GradeUndervalued
TypeBlend
Dividend Yield0.63%
Risk Assessment
Beta0.06
Volatility45.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.